Skip to main content
SpringerLink
Log in

The Initial Consultation: Malignant Disease

  • Chapter
  • First Online:
Breast Disease

  • 2267 Accesses

Abstract

There is a singular opportunity and inherent responsibility associated with the initial consult for a newly diagnosed breast malignancy. The quality of this encounter impacts the effectiveness of the entire care plan. The advent of percutaneous biopsy for the diagnosis of breast lesions has allowed us the ability to streamline our surgical planning and minimizing multiple, and often unnecessary, procedures. The recent popularization of a multidisciplinary approach to the treatment of breast cancer has emphasized the importance of identifying high-risk tumors in those patients that may benefit from neoadjuvant systemic therapy, genetic evaluation, and a comprehensive, collective decision-making process to improve outcomes. The surgeon is often the gatekeeper and the first physician to have a detailed discussion with breast cancer patients about their treatment options, both surgical and nonsurgical, that outlines both the sequence and clarity of their treatment plan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National Comprehensive Cancer Network (NCCN) Guidelines. Clinical factors in diagnosis and staging of newly diagnosed breast cancer. www.NCCN.org/patients. Accessed Mar 2013.

  2. Pruthi S, Brandt KR, Degnim AC, Goetz MP, Perez EA, Reynolds CA, et al. A multidisciplinary approach to the management of breast cancer. Part 1 – prevention and diagnosis. Mayo Clin Proc. 2007;82(8):999–1012.

    Article  CAS  PubMed  Google Scholar 

  3. Pruthi S, Boughey JC, Brandt KR, Degnim AC, Dy GK, Goetz MP, et al. A multidisciplinary approach to the management of breast cancer. Part 2 – therapeutic considerations. Mayo Clin Proc. 2007;82(9):1131–40.

    Article  CAS  PubMed  Google Scholar 

  4. Newman EA, Guest AB, Helvie MA, Roubidoux MA, Chang AE, Kleer CG, et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. 2006;107(10):2346–51.

    Article  PubMed  Google Scholar 

  5. Kaplan SH, Greenfield S, Ware JE. Assessing the effects of physician-patient interaction on the outcome of chronic disease. Med Care. 1989;27(3):S110–27.

    Article  CAS  PubMed  Google Scholar 

  6. Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky A, et al. Physicians’ decision-making style and psychosocial outcomes among cancer survivors. Patient Educ Couns. 2009;77(3):404–12.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Powell RW. Breast examination. Clinical methods. NCBI bookshop. Chapter 176. In: Breast examination. #1 Clinical methods. The history, physical, and laboratory examination. Boston: Butterworth Publishing; 1990. pp. 822–6.

    Google Scholar 

  8. Leenders MWH, Broeders M, Croese C, Richir MC, Go HLS, Langenhorst BL, et al. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer: to do or not to do? Breast J. 2012;21(4):578–83.

    Article  CAS  Google Scholar 

  9. Caretta-Weyer H, Sisney GA, Beckman C, et al. Impact of axillary ultrasound and core needle biopsy on the utility of intraoperative frozen section analysis and treatment decision making in women with invasive breast cancer. Am J Surg. 2012;204(3):308–14.

    Article  PubMed  Google Scholar 

  10. Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids. 2011;76(7):627–35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Shuster TD, Girshovich L, Whitney TM, Hughes KS. Multidisciplinary care for patients with breast cancer. Surg Clin North Am. 2000;80(2):505–33.

    Article  CAS  PubMed  Google Scholar 

  12. Rakovitch E, Mihai A, Pignol JP, Hanna W, Kwinter J, Chartier C, et al. Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Breast Cancer Res Treat. 2004;87(3):265–72.

    Article  PubMed  Google Scholar 

  13. Harris L, Fritsche K, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for use of tumor markers in breast cancer. J Clin Oncol. 2007;25(33):5287–311.

    Article  CAS  PubMed  Google Scholar 

  14. Ha GW, Yi MS, Lee BK, Youn HJ, Jung SH. Clinical outcome of magnetic resonance imaging detected additional lesions in breast cancer patient. J Breast Cancer. 2011;14(3):213–8.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Houssami N, Hayes DF. Review of preoperative magnetic resonance imaging in breast cancer: should MRI be performed on all women with newly diagnosed early stage breast cancer? CA Cancer J Clin. 2009;59(5):290–302.

    Article  PubMed  Google Scholar 

  16. Houssami N, Turner R, Morrow M. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg. 2013;257(2):249–55.

    Article  PubMed  Google Scholar 

  17. Marcos de Paz LM, Tejerina Bernal A, Arranza Merino ML, Calvo de Juan V. Breast MR imaging changes after neoadjuvant chemotherapy: correlation with molecular subtypes. Radiologia. 2012;54(5):442–8.

    Article  CAS  PubMed  Google Scholar 

  18. Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, et al. Impact of MRI evaluated neoadjuvant chemotherapy response on change of surgical recommendations in breast cancer. Ann Surg. 2009;249(3):448–54.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Güth U, Vetter M, Huang DJ, Heinzelmann-Schwarz V. Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative hormone receptor-negative disease. Ann Oncol. 2013;24(2):555–7.

    Article  PubMed  Google Scholar 

  20. Myers R, Johnston M, Pritchard K, Levine M, Oliver T, et al. Baseline staging tests in primary breast cancer: a practice guideline. Can Med Assoc J. 2001;164:1439–44.

    CAS  Google Scholar 

  21. Puglisi F, Follador A, Minisini AM, Cardellino GG, Russo S, Andreetta C, et al. Baseline staging tests after a new diagnosis of breast cancer; further evidence of their limited indications. Ann Oncol. 2005;16:263.

    Article  CAS  PubMed  Google Scholar 

  22. Gold J, Winer ED. Chapter 76: Chemotherapy for metastatic breast cancer. In: Copeland EM, editor. The breast: comprehensive management of benign and malignant diseases. Bland: Elsevier; 2013.

    Google Scholar 

  23. Ravaioli A, Pasini G, Polselli A, Papi M, Tassinari D, Arcangeli V, et al. Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat. 2002;72:53.

    Article  PubMed  Google Scholar 

  24. Moffat R, de Geyter C, Myrick ME, Schmid SM, Sattman C, Tschudin S, et al. Young women with breast cancer: how many are actually candidates for fertility preservation? Arch Gynecol Obstet. 2012;286(6):1521–7.

    Article  PubMed  Google Scholar 

  25. Christinat A, Pagani O. Fertility after breast cancer. Maturitas. 2012;73(3):191–6.

    Article  PubMed  Google Scholar 

  26. Litton JK. Breast cancer and fertility. Curr Treat Options Oncol. 2012;13(2):137–45.

    Article  PubMed  Google Scholar 

  27. Ottini L, Masala G, D’Amico C, Mancini B, Saieva C, Aceto G, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population based study in Italy. Cancer Res. 2003;63(2):342–7.

    CAS  PubMed  Google Scholar 

  28. Trost LW, Brannigan RE. Oncofertility and the male cancer patient. Curr Treat Options Oncol. 2012;13(2):146–60.

    Article  PubMed  Google Scholar 

  29. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(19):2500–10.

    Article  PubMed  Google Scholar 

  30. Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887–96.

    Article  CAS  PubMed  Google Scholar 

  31. Cardoso F, Loibl S, Pagani O, Graziottin A, Panizza P, Martincich L, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer. 2012;48(18):3355–77.

    Article  PubMed  Google Scholar 

  32. Berry DL, Theriault RL, Holmes FA, Parisi VM, Booser DJ, Singletary SE, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17(3):855–61.

    CAS  PubMed  Google Scholar 

  33. Meisel JL, Economy KE, Calvillo KZ, Schapira L, Tung NM, Gelber S, et al. Contemporary multidisciplinary treatment of pregnancy associated breast cancer. Springerplus. 2013;2(1):297.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Cancer Program, Advocate Cancer Institute, Advocate Christ Medical Center, 4400 West 95th Street, Suite 107 POB 408, Oak Lawn, IL, 60453, USA

    Barbara L. Krueger MD, FACS

  2. Advocate Center for Breast Health, Advocate Cancer Institute, Advocate Christ Medical Center, 4400 West 95th Street, Suite 107 POB 408, Oak Lawn, IL, 60453, USA

    Adam I. Riker MD, FACS

Authors
  1. Barbara L. Krueger MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam I. Riker MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara L. Krueger MD, FACS .

Editor information

Editors and Affiliations

  1. Advocate Center for Breast Health, Advocate Cancer Institute, Oak Lawn, Illinois, USA

    Adam I. Riker

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Krueger, B.L., Riker, A.I. (2015). The Initial Consultation: Malignant Disease. In: Riker, A. (eds) Breast Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1145-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1145-5_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1144-8

  • Online ISBN: 978-1-4939-1145-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation